InsidersTradesSigma
Follow the The Oncology Institute, Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €512.9m. The latest transaction was filed on 14 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: YALE PODNOS. Every trade is openly available.
Analysts rate The Oncology Institute, Inc. Strong Buy (bullish), based on 5 analysts. Average price target: US$8.40.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
The Oncology Institute, Inc. is a company focused on providing cancer care services. It operates on the XNAS stock market.